As public officials and providers fret over the safety and cost of drugs bought from compounding pharmacies, more hospital systems are working on plans to mix and package the drugs themselves.
The multistate meningitis outbreak last year that led to 48 deaths and sickened another 714 people was caused by contaminated steroid injections produced by the New England Compounding Center.
Hundreds of hospitals in the U.S. purchased compounded drugs from NECC and Ameridose, a national compounder that shares ownership with NECC.
The outbreak triggered calls for stronger federal and state oversight of compounding pharmacies, especially for companies such as NECC and Ameridose that were operating more like drug manufacturers than traditional compounders before they closed last year.
“The tipping point for people who were close to making that decision was probably the Ameridose closure,” said Erin Fox, director of the drug information service at the University of Utah Hospitals and Clinics. “It was a wake-up call. They certainly trusted NECC and they trusted Ameridose.”
Read more: Hospitals turn to compound drugs because of quality, cost | Modern Healthcare http://www.modernhealthcare.com/article/20130302/MAGAZINE/303029974#ixzz2MVZmyUCe
?trk=tynt
The multistate meningitis outbreak last year that led to 48 deaths and sickened another 714 people was caused by contaminated steroid injections produced by the New England Compounding Center.
Hundreds of hospitals in the U.S. purchased compounded drugs from NECC and Ameridose, a national compounder that shares ownership with NECC.
The outbreak triggered calls for stronger federal and state oversight of compounding pharmacies, especially for companies such as NECC and Ameridose that were operating more like drug manufacturers than traditional compounders before they closed last year.
“The tipping point for people who were close to making that decision was probably the Ameridose closure,” said Erin Fox, director of the drug information service at the University of Utah Hospitals and Clinics. “It was a wake-up call. They certainly trusted NECC and they trusted Ameridose.”
Read more: Hospitals turn to compound drugs because of quality, cost | Modern Healthcare http://www.modernhealthcare.com/article/20130302/MAGAZINE/303029974#ixzz2MVZmyUCe
?trk=tynt
No comments:
Post a Comment